Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Chiron and Xoma collaborate to develop therapeutic antibodies for cancer

March 5, 2004

Novel CDK inhibitor with in vitro antiapoptotic activity described

March 4, 2004

ARH-460-16-2 set to enter clinic early next year

March 4, 2004

New protein kinase inhibitors for cancer and other disorders discovered at Janssen

March 4, 2004

MDM2 directly suppresses p21: broader anticancer activity for antisense MDM2 inhibitors

March 4, 2004

Satraplatin shows in vitro efficacy in tumor cells resistant to Taxotere and Taxol

March 3, 2004

Preclinical data supports use of INGN-241 regimens for lung, breast cancer

March 3, 2004

Novel HDAC inhibitors prepared and tested by 4SC and G2M scientists

March 3, 2004

Reolysin program update

March 3, 2004

Genzyme to acquire Ilex Oncology

March 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...